XOMA Royalty Corporation

Contributing Author

Recent Articles by XOMA Royalty Corporation

Dec-05	XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc XOMA GlobeNewswire
Nov-21	XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. XOMA GlobeNewswire
Nov-12	XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements XOMA GlobeNewswire
Sep-22	XOMA Royalty Declares Quarterly Preferred Stock Dividends XOMA GlobeNewswire
Sep-17	XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc. XOMA GlobeNewswire
Sep-03	XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference XOMA GlobeNewswire
Aug-20	Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share XOMA GlobeNewswire
Aug-13	XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements XOMA GlobeNewswire
Aug-11	XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics XOMA GlobeNewswire
Aug-04	HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right XOMA GlobeNewswire
Jun-18	XOMA Royalty Declares Quarterly Preferred Stock Dividends XOMA GlobeNewswire
May-13	XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements XOMA GlobeNewswire
May-07	XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference XOMA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.